Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18Colorectal Neoplasms 16Rectal Neoplasms 11Colonic Neoplasms 8Stomach Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Anus Neoplasms 4Adenocarcinoma Of Esophagus 4Squamous Cell Carcinoma of Head and Neck 3Pancreatic Adenocarcinoma 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Esophageal Neoplasms 3Clinical Stage I Gastric Cancer AJCC v8 3Cholangiocarcinoma 3Oropharyngeal Neoplasms 2Lung Neoplasms 2Klatskin Tumor 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Borderline Resectable Pancreatic Adenocarcinoma 2Bile Duct Neoplasms 2Appendiceal Neoplasms 2Anal Canal Carcinoma 2Uterine Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1

Interventions

Doxorubicin 20Vincristine 17Zidovudine 13Cyclophosphamide 12Bleomycin 12Etoposide 10Rituximab 6Prednisone 6Interferon alpha-2 6Cytarabine 6Liposomes 5Filgrastim 5Dexamethasone 5tecogalan 4sargramostim 4Specimen Handling 4Methotrexate 4Magnetic Resonance Spectroscopy 4Leucovorin 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Fluorouracil 4Biopsy 4Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Nivolumab 3interferon alfa-n1 2fludarabine phosphate 2fludarabine 2cabozantinib 2Whole-Body Irradiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × HIV Infections × dehydroftorafur × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡